Drug recall D-0329-2021
Product
Candesartan Cilexetil Tablets, USP, 4 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Daman (U.T.), India, NDC 33342-114-10
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lots # : ECD5908C, Exp 7/2021; ECD5909A, ECD5910A, ECD5911A, ECD5912A, Exp. 09/2021.
Recall details
- Recalling firm
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Quantity
- 8015 packs
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 22, 2021
- Terminated
- December 13, 2022
Related products
- Candesartan – drug information
- NDC 33342-115 Candesartan · Candesartan Cilexetil 8 mg/1 · Macleods Pharmaceuticals Limited
- NDC 33342-116 Candesartan · Candesartan Cilexetil 16 mg/1 · Macleods Pharmaceuticals Limited
- NDC 33342-117 Candesartan · Candesartan Cilexetil 32 mg/1 · Macleods Pharmaceuticals Limited
- NDC 33342-114 Candesartan · Candesartan Cilexetil 4 mg/1 · Macleods Pharmaceuticals Limited